Showing results (1221-1230 of 1,336) with videos related to

Sort By:
Pageof 134
Molecular Genetics and Metabolism|March 2, 2010
Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders ConsortiumJennifer Seminara, Mendel Tuchman, Lauren Krivitzky, et al.
Artificial Organs|September 30, 2015
Development of a Magnetic Attachment Method for Bionic Eye ApplicationsKate Fox, Hamish Meffin, Owen Burns, et al.
Brachytherapy|September 13, 2023
The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countriesSurbhi Grover, Katie E Lichter, Anna Likhacheva, et al.
Acta Neuropathologica|June 5, 2012
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasDong-Anh Khuong-Quang, Pawel Buczkowicz, Patricia Rakopoulos, et al.
Genes, Chromosomes & Cancer|October 2, 2008
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusCarsten Schwaenen, Andreas Viardot, Hilmar Berger, et al.
International Journal of Cancer|February 10, 2016
Telomere dysfunction and chromothripsisAurélie Ernst, David T W Jones, Kendra K Maass, et al.
Acta Neuropathologica|December 17, 2013
Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entityAndrey Korshunov, Dominik Sturm, Marina Ryzhova, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
Nature Communications|May 10, 2020
The landscape of chromothripsis across adult cancer typesNatalia Voronina, John K L Wong, Daniel Hübschmann, et al.
Breast Cancer Research and Treatment|October 1, 2011
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerFrederik Marmé, Wiebke Werft, Anne Walter, et al.
Pageof 134